True Wealth Design
SMMT icon

True Wealth Design’s Summit Therapeutics SMMT Stock Holding History

True Wealth Design’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.35K Buy
139
+129
+1,290% +$1.93K ﹤0.01% 1618
2026
Q2 		$146 Buy
10
+7
+233% +$124 ﹤0.01% 2498
2026
Q1 		$57 Sell
3
-3
-50% -$49 ﹤0.01% 2554
2025
Q4 		$105 Sell
6
-1
-14% -$19 ﹤0.01% 2339
2025
Q3 		$145 Sell
7
-11
-61% -$267 ﹤0.01% 2374
2025
Q2 		$384 Buy
18
+14
+350% +$319 ﹤0.01% 1844
2025
Q1 		$78 Hold
4
– – ﹤0.01% 2281
2024
Q4 		$72 Buy
+4
New +$78 ﹤0.01% 1298

Other funds holding SMMT

Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Wealth Management Partners
Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Blankinship & Foster
Blankinship & Foster Solana Beach, California $490M AUM 14.37% 1-Year Est. Return

True Wealth Design's SMMT Position: Q3 2026 in Review

True Wealth Design increased its Summit Therapeutics (SMMT) stake by 1,290% in Q3 2026, buying an estimated $1.93K and bringing the position to 139 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

True Wealth Design first reported a position in SMMT in Q4 2024 and has held it in 8 quarters since. 32 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • True Wealth Design held 139 shares of Summit Therapeutics worth $2.35K as of Q3 2026.
  • True Wealth Design bought 129 Summit Therapeutics shares in Q3 2026, an estimated $1.93K.
  • Summit Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1618 holding.
  • True Wealth Design first reported a position in Summit Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • 32 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.